Fucidin cream at a glance
Fucidin 20 mg/g cream is a topical antibacterial medicine used to treat susceptible bacterial skin infections. Its active ingredient is fusidic acid, present at a strength of 20 mg per gram (2%). It functions specifically as an antibiotic by targeting bacteria rather than acting as a general treatment for inflammation, itching, or non-infected damaged skin. The product contains no corticosteroid or antifungal agents, meaning it does not treat the underlying cause of inflammatory skin conditions such as ordinary eczema unless those conditions are complicated by a secondary bacterial infection.
Bacterial skin infections Fucidin cream is used for
Fucidin cream is indicated for primary and secondary skin infections caused by susceptible strains of specific bacteria, including Staphylococcus aureus, Streptococcus species, and Corynebacterium minutissimum. The UK label lists several distinct conditions where this antibacterial action is appropriate.
Primary bacterial skin infections covered by the indication include impetigo contagiosa, superficial folliculitis, sycosis barbae, and paronychia. It is also used for erythrasma and infected cuts or abrasions. In these cases, the cream directly targets the initial bacterial cause of the skin lesion.
The product is also indicated for secondary bacterial infections complicating existing inflammatory skin conditions. This includes infected eczematoid dermatitis and infected contact dermatitis. Distinguish between the two: Fucidin treats the bacterial infection that has developed on top of the damaged skin barrier, but it does not treat the underlying chronic condition itself. The antibiotic addresses the complication, not the root cause of the eczema or dermatitis.
Conditions Fucidin cream does not treat
Because Fucidin is a specific antibacterial agent, it has no effect on skin conditions caused by viruses or fungi. It is not an antifungal treatment for issues such as ringworm, athlete's foot, or thrush, nor is it an antiviral medicine for infections like cold sores or chickenpox. Using Fucidin in these cases will not resolve the underlying infection and may delay appropriate care.
The product is also not a general treatment for non-infected inflammatory skin problems. Ordinary eczema, dermatitis, contact irritation, shivering bumps, or simple rashes without signs of bacterial involvement do not require an antibiotic. Fucidin does not reduce itching, redness, or swelling associated with purely inflammatory conditions, and it should not be used as a routine cream for these symptoms.
Fucidin is not indicated for routine acne, spots, or uninfected wounds. It does not accelerate wound healing, prevent infection in clean cuts, or treat superficial skin damage such as burns or shaving irritation. The UK label does not support its use for non-infected inflammatory disease, and applying it to areas without a susceptible bacterial infection offers no therapeutic benefit. Because visual appearance alone cannot reliably distinguish between bacterial, viral, fungal, or purely inflammatory causes, using the cream for suspected but unconfirmed conditions is inappropriate. If a skin lesion does not appear to be a confirmed bacterial infection, a different treatment approach guided by a healthcare professional may be necessary.
Fucidin Cream Knowledge Check
Fucidin cream versus Fucidin H cream
The key difference between the two products lies in their active ingredients and intended use cases. Plain Fucidin cream contains only fusidic acid (2%) to fight bacterial infection. It is used for any of the susceptible bacterial skin infections listed on its label, from impetigo to infected abrasions.
Fucidin H cream is a combination product containing both fusidic acid 2% and hydrocortisone acetate 1%, which is a mild corticosteroid. The UK indication for Fucidin H is specific: it is used for eczema or dermatitis that has developed a secondary bacterial infection. The steroid component helps reduce the inflammation, redness, and itching associated with the underlying eczema, while the fusidic acid treats the accompanying bacterial infection.
It is a common misconception that Fucidin H is simply a “stronger” version of plain Fucidin for more severe infections. This is not accurate. The two products have different indications. Plain Fucidin should be used when a bacterial infection is present without significant inflammatory eczema, or when the underlying eczema requires separate management. Fucidin H is reserved for cases where both steroid treatment and antibiotic coverage are clinically appropriate.
Because Fucidin H contains a steroid, it carries additional precautions not found in plain Fucidin. The UK label advises that treatment with Fucidin H should normally not exceed two weeks. Long-term use of topical steroids can cause skin thinning and other local side effects. Fucidin H has specific contraindications for certain skin conditions where steroids are harmful, such as acne rosacea or perioral dermatitis. The choice between the two depends entirely on whether an underlying inflammatory condition requires steroid therapy alongside antibiotic treatment.
How to apply Fucidin cream
The UK product label directs that adults and children should apply Fucidin cream gently to uncovered lesions three or four times daily. For skin areas that are routinely covered by clothing, less frequent application may be adequate. These instructions provide general guidance; the specific directions provided by a prescriber or found on the individual pack leaflet take precedence for an individual course of treatment.
NHS guidance adds practical steps to ensure safe and effective use. Hands should be washed before applying the cream. Unless the hands themselves are being treated, they should also be washed afterwards. A thin layer of the cream should be applied and rubbed in gently. The product must not come into contact with the eyes. If accidental contact occurs, the area should be rinsed thoroughly with water.
A specific safety precaution relates to the cream's flammability. Clothing, bedding, and dressings treated with Fucidin burn more easily than untreated materials. Users must avoid smoking or being near naked flames while applying or using the cream. Washing the affected fabric reduces but does not eliminate this product build-up and associated fire risk.
How long treatment takes and when improvement may appear
Patients using Fucidin cream should expect visible improvement in their skin condition within a few days of starting treatment. The absence of immediate results does not necessarily indicate treatment failure, as bacterial clearance takes time.
The UK NHS guidance states that a course of topical fusidic acid for general skin infections usually lasts one or two weeks, though it may be longer depending on the severity and location of the infection. Complete the full course directed by a healthcare professional, even if the skin appears clear earlier. Stopping treatment prematurely can allow surviving bacteria to multiply, potentially leading to recurrence or resistance.
Treatment duration varies significantly by specific condition. For impetigo, NICE guidelines recommend a shorter, targeted course of five days when topical fusidic acid is selected. This may be extended to seven days based on clinical judgment. These specific timelines should not be generalized to other indications such as infected eczema or folliculitis, which may require different durations.
Improvement within the expected timeframe depends on appropriate diagnosis and adherence to application instructions. If a condition worsens, spreads, or shows no signs of improvement after the initial few days, medical reassessment is required. For persistent impetigo that fails to improve after a topical antibiotic course, NICE advises switching to an oral antibiotic and considering a skin swab to identify the specific bacteria and its sensitivity profile.
Recurrence of symptoms after completing treatment may indicate reinfection or a resistant strain, warranting further microbiological assessment. If the initial diagnosis was incorrect-for example, if the rash is fungal or viral rather than bacterial-Fucidin will not resolve the issue, and alternative treatments guided by a clinician will be necessary.
Side effects, precautions, and antibiotic resistance
The most common adverse effects of Fucidin cream are local skin reactions at the application site. The UK product label lists uncommon occurrences of dermatitis, rash, itching, redness, pain, burning sensation, or general irritation. These symptoms typically resolve once treatment concludes or may subside with continued use if they are mild.
Rare but more serious allergic reactions can occur. These include hypersensitivity responses such as hives (urticaria), angioedema (swelling of the deeper skin layers), blistering, and conjunctivitis if the product migrates to the eyes. Because the excipients in the cream formulation can also trigger local skin reactions, individuals with known sensitivities should exercise caution. Care is specifically required when applying the product near the eyes to avoid direct contact.
Antibiotic stewardship is a critical component of using Fucidin cream. Extended or recurrent use of topical fusidic acid can increase the risk of developing bacterial resistance. Future infections caused by Staphylococcus aureus or other susceptible bacteria may become harder to treat with this specific antibiotic. Prolonged exposure to the medication can increase the likelihood of contact sensitisation, where the skin becomes increasingly allergic to fusidic acid itself.
To mitigate these risks, Fucidin cream should not be shared between individuals, nor should leftover cream be saved for future use. It is indicated only for confirmed or strongly suspected susceptible bacterial infections. Using the cream prophylactically on uninfected wounds, or extending the course beyond what is medically necessary, offers no benefit and actively contributes to resistance patterns.
The flammability precaution mentioned earlier also serves as a broader safety measure. Because treated fabrics burn more easily, users must avoid smoking and naked flames. Washing contaminated clothing reduces but does not eliminate this risk, so careful handling of bedding and garments remains essential throughout the course of treatment.
When to seek medical advice
Fucidin cream should be stopped and a healthcare professional consulted if the skin condition worsens or shows no signs of improvement within the expected timeframe. For impetigo specifically, NICE guidelines recommend reassessment if the infection fails to improve after a course of topical antibiotics. In such cases, the clinical approach may shift to an oral antibiotic, and a skin swab might be taken to identify the specific bacteria and its sensitivity profile. Recurrent impetigo also warrants microbiological assessment rather than simply restarting the cream.
If the rash spreads, becomes more painful, or develops signs of deeper infection such as increased warmth or swelling, medical evaluation is necessary. Visual symptoms alone, such as redness, crusting, or itching, do not confirm a bacterial cause. If the condition was misdiagnosed and is actually fungal or viral, Fucidin will have no effect, and delaying appropriate treatment could allow the primary infection to progress.
Immediate medical attention is required if signs of a severe allergic reaction appear. The UK label identifies rare but serious hypersensitivity reactions including angioedema (swelling of the deeper skin layers), hives, blistering, and conjunctivitis. Urgent care should be sought if swelling involves the mouth, throat, or lips, or if breathing becomes difficult. These symptoms indicate a systemic allergic response that requires prompt intervention beyond stopping the topical application.
Fucidin 20 mg/g cream is a topical antibiotic containing fusidic acid 2% for susceptible bacterial skin infections. It is used for listed primary bacterial infections such as impetigo, for infected cuts or abrasions, and for secondary bacterial infection complicating eczema or dermatitis. It is not an antifungal or antiviral and does not treat the underlying inflammatory condition in non-infected eczema, dermatitis, simple rashes, routine acne, or uninfected wounds. It also does not reduce itching, redness, or swelling when no bacterial infection is present, and using it for viral, fungal, or unconfirmed causes may delay appropriate care.
Plain Fucidin contains only fusidic acid and is not the same as Fucidin H, which also contains hydrocortisone 1% and is indicated specifically for eczema or dermatitis with a secondary bacterial infection. Fucidin H is not simply a stronger version of plain Fucidin. It is normally not used longer than two weeks and has specific contraindications where topical steroids are harmful, such as acne rosacea or perioral dermatitis. The choice depends on whether an underlying inflammatory condition requires steroid treatment alongside an antibiotic.
Adults and children usually apply a thin layer gently to uncovered lesions three or four times daily, less often for areas covered by clothing; prescriber or pack instructions take precedence. Wash hands before and after unless treating the hands, avoid eye contact, and rinse thoroughly if contact occurs. Treated clothing, bedding, and dressings are more flammable, so avoid smoking and naked flames; washing reduces but does not eliminate the risk. Improvement should appear within a few days, and topical fusidic acid courses generally last one or two weeks, with shorter specific regimens for impetigo, and the full course should be completed. Stop and seek advice if the condition worsens, spreads, or does not improve as expected. Local skin reactions are the most common side effects, while rare serious allergic reactions require immediate attention, especially swelling of the mouth, throat, or lips or difficulty breathing. Extended or recurrent use can promote resistance and contact sensitisation, so the cream should not be shared, saved for future use, or used prophylactically on uninfected wounds.
Source organization: electronic Medicines Compendium
Source organization: NHS
Source organization: National Institute for Health and Care Excellence
Questions & comments
Please do not include passwords, medical record numbers, insurance information, financial information, precise addresses, or other confidential or directly identifying information in your message.